BioLife Solutions (BLFS) Stock Price

BioLife Solutions Price

NASDAQ·CLOSED
28.18USD-0.05 (-0.18 %)
Market closed

Revenue has compounded at 30.6% per year over the past 19 years to 96.21 M USD. BioLife Solutions's net margin stands at -4.8%, up from -7.5% several years earlier. Analysts set a median price target of 32.64 USD, implying 15.8% above the current price. Of 16 analysts, 15 rate the stock a buy — an overall Buy consensus. The stock trades about 55% above its 52-week low.

BioLife Solutions stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of BioLife Solutions over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how BioLife Solutions stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing BioLife Solutions's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

BioLife Solutions Stock Price History
DateBioLife Solutions Price
7/10/202628.18 USD
7/9/202628.23 USD
7/8/202627.39 USD
7/7/202627.93 USD
7/6/202627.79 USD
7/2/202628.11 USD
7/1/202628.49 USD
6/30/202628.24 USD
6/29/202628.67 USD
6/26/202628.67 USD
6/25/202627.50 USD
6/24/202625.57 USD
6/23/202624.79 USD
6/22/202625.33 USD
6/18/202625.91 USD
6/17/202626.63 USD
6/16/202626.42 USD
6/15/202626.81 USD
6/12/202627.12 USD
6/11/202626.53 USD
6/10/202627.89 USD
6/9/202627.55 USD
6/8/202626.10 USD
6/5/202626.42 USD
6/4/202627.43 USD
6/3/202627.37 USD
6/2/202626.95 USD
6/1/202626.75 USD
5/29/202625.07 USD
5/28/202625.44 USD
5/27/202624.41 USD
5/26/202624.07 USD
5/22/202624.09 USD
5/21/202624.01 USD
5/20/202623.58 USD
5/19/202623.05 USD
5/18/202622.30 USD
5/15/202620.76 USD
5/14/202621.06 USD
5/13/202621.17 USD
5/12/202621.23 USD
5/11/202621.73 USD
5/8/202622.04 USD
5/7/202623.12 USD
5/6/202621.75 USD
5/5/202621.55 USD
5/4/202621.09 USD
5/1/202621.21 USD
4/30/202621.08 USD
4/29/202619.99 USD
4/28/202620.90 USD
4/27/202621.41 USD
4/24/202621.38 USD
4/23/202621.72 USD
4/22/202622.80 USD
4/21/202622.37 USD
4/20/202622.19 USD
4/17/202621.50 USD
4/16/202620.85 USD
4/15/202621.19 USD
4/14/202620.27 USD
4/13/202620.11 USD
4/10/202619.74 USD
4/9/202620.48 USD
4/8/202619.71 USD
4/7/202619.13 USD
4/6/202619.27 USD
4/5/202619.27 USD
4/2/202619.51 USD
4/1/202619.51 USD
3/31/202619.29 USD
3/30/202619.08 USD
3/29/202618.78 USD
3/27/202618.59 USD
3/26/202618.59 USD
3/25/202619.65 USD
3/24/202619.86 USD
3/23/202619.70 USD
3/22/202619.17 USD
3/20/202618.85 USD
3/19/202618.85 USD
3/18/202619.53 USD
3/17/202619.12 USD
3/16/202619.40 USD
3/15/202619.08 USD
3/13/202618.36 USD
3/12/202618.36 USD
3/11/202618.15 USD
3/10/202619.01 USD
3/9/202618.67 USD
3/8/202619.90 USD
3/6/202619.86 USD
3/5/202619.86 USD
3/4/202620.12 USD
3/3/202620.67 USD
3/2/202620.17 USD
3/1/202622.52 USD
2/27/202624.20 USD
2/26/202624.20 USD
2/25/202622.48 USD
2/24/202622.47 USD
2/23/202622.65 USD
2/22/202622.88 USD
2/20/202623.09 USD
2/19/202623.09 USD
2/18/202623.23 USD
2/17/202622.84 USD
2/16/202622.36 USD
2/13/202622.23 USD
2/12/202622.23 USD
2/11/202621.58 USD
2/10/202622.25 USD
2/9/202622.65 USD
2/8/202622.63 USD
2/6/202622.43 USD
2/5/202622.43 USD
2/4/202622.02 USD
2/3/202622.67 USD
2/2/202622.84 USD
2/1/202622.33 USD
1/30/202621.80 USD
1/29/202621.80 USD
1/28/202622.58 USD
1/27/202622.94 USD
1/26/202624.98 USD
1/25/202624.94 USD
1/23/202624.87 USD
1/22/202624.87 USD
1/21/202625.98 USD
1/20/202625.55 USD
1/19/202624.76 USD
1/16/202624.42 USD
1/15/202624.42 USD
1/14/202624.47 USD
1/13/202624.29 USD
1/12/202623.90 USD
1/11/202624.04 USD
1/9/202624.86 USD
1/8/202624.86 USD
1/7/202624.95 USD
1/6/202625.41 USD
1/5/202626.35 USD
1/4/202625.31 USD
1/2/202623.89 USD
1/1/202623.89 USD
12/31/202524.18 USD
12/30/202524.18 USD
12/29/202524.66 USD
12/28/202525.12 USD
12/26/202524.90 USD
12/25/202524.90 USD
12/24/202525.41 USD
12/23/202525.41 USD
12/22/202525.46 USD
12/21/202525.47 USD
12/19/202525.07 USD
12/18/202525.07 USD
12/17/202525.34 USD
12/16/202525.01 USD
12/15/202524.61 USD
12/14/202524.65 USD
12/12/202524.39 USD
12/11/202524.39 USD
12/10/202524.88 USD
12/9/202524.77 USD
12/8/202524.75 USD
12/7/202524.95 USD
12/5/202525.46 USD
12/4/202525.46 USD
12/3/202525.83 USD
12/2/202525.51 USD
12/1/202525.37 USD
11/30/202525.41 USD
11/28/202526.50 USD
11/27/202526.50 USD
11/26/202526.68 USD
11/25/202526.68 USD
11/24/202526.99 USD
11/23/202526.35 USD
11/21/202526.53 USD
11/20/202526.53 USD
11/19/202524.20 USD
11/18/202524.38 USD
11/17/202524.03 USD
11/16/202524.01 USD
11/14/202524.07 USD
11/13/202524.07 USD
11/12/202525.14 USD
11/11/202525.92 USD
11/10/202526.04 USD
11/9/202526.29 USD
11/7/202525.93 USD
11/6/202525.93 USD
11/5/202527.02 USD
11/4/202527.57 USD
11/3/202527.11 USD
11/2/202527.87 USD
10/31/202527.87 USD
10/30/202527.87 USD
10/29/202526.90 USD
10/28/202527.54 USD
10/27/202527.98 USD
10/26/202528.04 USD
10/23/202528.79 USD
10/22/202528.66 USD
10/21/202527.54 USD
10/20/202527.68 USD
10/19/202527.86 USD
10/16/202527.32 USD
10/15/202527.73 USD
10/14/202528.75 USD
10/13/202527.66 USD
10/12/202527.42 USD
10/9/202526.80 USD
10/8/202527.45 USD
10/7/202527.34 USD
10/6/202526.30 USD
10/5/202526.52 USD
10/2/202526.59 USD
10/1/202525.91 USD
9/30/202526.13 USD
9/29/202525.51 USD
9/28/202524.52 USD
9/25/202524.70 USD
9/24/202524.18 USD
9/23/202524.11 USD
9/22/202524.75 USD
9/21/202525.28 USD
9/18/202525.57 USD
9/17/202526.28 USD
9/16/202525.59 USD
9/15/202525.98 USD
9/14/202525.80 USD
9/11/202525.51 USD
9/10/202526.74 USD
9/9/202526.49 USD
9/8/202526.40 USD
9/7/202526.22 USD
9/4/202526.46 USD
9/3/202525.87 USD
9/2/202525.04 USD
9/1/202525.34 USD
8/28/202525.05 USD
8/27/202524.92 USD
8/26/202525.43 USD
8/25/202525.65 USD
8/24/202525.65 USD
8/21/202525.91 USD
8/20/202525.08 USD
8/19/202524.96 USD
8/18/202524.54 USD
8/17/202524.50 USD
8/14/202524.34 USD
8/13/202525.32 USD
8/12/202525.68 USD
8/11/202524.06 USD
8/10/202522.37 USD
8/7/202522.68 USD
8/6/202520.64 USD
8/5/202521.09 USD
8/4/202520.73 USD
8/3/202520.89 USD
7/31/202520.81 USD
7/30/202521.26 USD
7/29/202521.82 USD
7/28/202522.10 USD
7/27/202522.23 USD
7/24/202522.58 USD
7/23/202522.26 USD
7/22/202522.45 USD
7/21/202521.41 USD
7/20/202520.76 USD
7/17/202520.83 USD
7/16/202521.42 USD
7/15/202521.04 USD
7/14/202520.78 USD
7/13/202522.02 USD
Access this data via the Eulerpool API
Get Free API Key

BioLife Solutions Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
68.02 M USD
-17.21 M USD
-68.00 M USD
Jan 1, 2024
74.65 M USD
-4.48 M USD
-20.18 M USD
Jan 1, 2025
96.21 M USD
-1.08 M USD
-4.60 M USD
Jan 1, 2026 (e)
115.20 M USD
5.27 M USD
7.14 M USD
Jan 1, 2027 (e)
135.73 M USD
15.30 M USD
19.73 M USD
Jan 1, 2028 (e)
164.95 M USD
36.15 M USD
41.40 M USD
Jan 1, 2029 (e)
200.57 M USD
45.33 M USD
41.40 M USD
Jan 1, 2030 (e)
247.70 M USD
70.36 M USD
56.02 M USD

BioLife Solutions Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 8:47 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
8.0011.0019.0027.0048.00119.00161.0068.0074.0096.00115.00135.00164.00200.00247.00310.00
33.3337.5072.7342.1177.78147.9235.29-57.768.8229.7319.7917.3921.4821.9523.5025.51
50.0054.5568.4266.6756.2531.0932.9260.2967.5764.5864.5864.5864.5864.5864.5864.58
4.006.0013.0018.0027.0037.0053.0041.0050.0062.0074.2787.19105.92129.17159.52200.21
-6.00-2.00-25.00-1.001.00-8.00-139.00-68.00-20.00-4.007.0019.0041.0041.0056.00–
50.00-66.671,150.00-96.00-200.00-900.001,637.50-51.08-70.59-80.00-275.00171.43115.79–36.59–
12.6013.3016.3019.5027.3038.5042.5043.7246.0747.7547.7547.7547.7547.7547.7547.75
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales BioLife Solutions generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue BioLife Solutions retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare BioLife Solutions's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares BioLife Solutions has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against BioLife Solutions's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

BioLife Solutions stock margins

The BioLife Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioLife Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioLife Solutions.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
31.04 %
-28.10 %
-7.47 %
Jan 1, 2022
33.25 %
-21.69 %
-86.40 %
Jan 1, 2023
60.75 %
-25.30 %
-99.98 %
Jan 1, 2024
67.11 %
-6.00 %
-27.04 %
Jan 1, 2025
64.56 %
-1.12 %
-4.78 %
Jan 1, 2026 (e)
64.56 %
4.57 %
6.20 %
Jan 1, 2027 (e)
64.56 %
11.27 %
14.53 %
Jan 1, 2028 (e)
64.56 %
21.92 %
25.10 %

BioLife Solutions Stock Revenue, EBIT, Earnings per Share

The BioLife Solutions earnings per share therefore indicates how much revenue BioLife Solutions has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
3.10 USD
-0.87 USD
-0.23 USD
Jan 1, 2022
3.81 USD
-0.83 USD
-3.29 USD
Jan 1, 2023
1.56 USD
-0.39 USD
-1.56 USD
Jan 1, 2024
1.62 USD
-0.10 USD
-0.44 USD
Jan 1, 2025
2.01 USD
-0.02 USD
-0.10 USD
Jan 1, 2026 (e)
2.41 USD
0.11 USD
0.15 USD
Jan 1, 2027 (e)
2.84 USD
0.32 USD
0.41 USD
Jan 1, 2028 (e)
3.45 USD
0.76 USD
0.87 USD

BioLife Solutions business model & stock analysis

BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry.

BioLife Solutions SWOT Analysis

Strengths

1. Strong product portfolio: BioLife Solutions Inc offers a diverse range of innovative biopreservation tools and services, which cater to the growing needs of the biotech and pharmaceutical industries.

2. Established reputation: The company has built a solid reputation for delivering high-quality, reliable products, ensuring customer satisfaction and loyalty.

3. Robust research and development: BioLife Solutions Inc invests heavily in R&D, allowing them to stay at the forefront of technological advancements and develop cutting-edge solutions for their customers.

Weaknesses

1. Dependence on a few key customers: The company relies heavily on a small number of customers for a significant portion of its revenue, making it vulnerable to any changes in their preferences or buying patterns.

2. Limited global presence: BioLife Solutions Inc primarily operates in North America, which restricts its market reach and potential growth opportunities in other geographical regions.

3. Relatively small market share: Despite being a leader in biopreservation solutions, the company faces intense competition from larger, more established players in the industry.

Opportunities

1. Growing biotech and pharmaceutical sectors: The increasing demand for biopreservation tools and services presents immense growth opportunities for BioLife Solutions Inc.

2. Expansion into international markets: Exploring and expanding operations in new geographical regions would help the company tap into untapped markets and increase its customer base.

3. Strategic partnerships and collaborations: Forming partnerships with other industry players or research institutions could enhance BioLife Solutions Inc's capabilities and open doors to new technologies and markets.

Threats

1. Competitive market landscape: The biopreservation industry is highly competitive, with numerous established and emerging players vying for market share, which could potentially impact BioLife Solutions Inc's growth and profitability.

2. Regulatory challenges: Changes in government regulations pertaining to biopreservation or concerns related to product safety can pose challenges and increase compliance costs for the company.

3. Economic uncertainties: Global economic fluctuations or downturns may affect the spending capacity of BioLife Solutions Inc's customers, potentially impacting their demand for biopreservation products and services.

BioLife Solutions Segments

BioLife Solutions Revenue by Segment

  • 3 Years

  • 5 Years

  • Max

Product
Biopreservation Media
Regenerative Medicine
Distribution Service
Freezers and Accessories
Drug Discovery
Automated Thawing Products
BioBanking
Evo Shippers
Rental Revenue
Details
Date
Product
Biopreservation Media
Regenerative Medicine
Distribution Service
Freezers and Accessories
Drug Discovery
Automated Thawing Products
BioBanking
Evo Shippers
Rental Revenue
Jan 1, 2018
0.00 USD
0.00 USD
11.03 M USD
6.42 M USD
0.00 USD
1.20 M USD
0.00 USD
1.10 M USD
0.00 USD
0.00 USD
Jan 1, 2019
26.84 M USD
23.36 M USD
0.00 USD
0.00 USD
2.14 M USD
0.00 USD
1.18 M USD
0.00 USD
692,000.00 USD
527,000.00 USD

BioLife Solutions Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

BioLife Solutions historical P/E ratio, EBIT multiple, and P/S ratio

BioLife Solutions annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

BioLife Solutions shares outstanding

The number of shares of BioLife Solutions was 47.75 M in 2025. This indicates how many shares BioLife Solutions is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
38.50 M Stocks
Jan 1, 2022
42.50 M Stocks
Jan 1, 2023
43.72 M Stocks
Jan 1, 2024
46.07 M Stocks
Jan 1, 2025
47.75 M Stocks
Jan 1, 2026 (e)
47.75 M Stocks
Jan 1, 2027 (e)
47.75 M Stocks
Jan 1, 2028 (e)
47.75 M Stocks

BioLife Solutions stock splits

In BioLife Solutions's history, there have been no stock splits.

Current BioLife Solutions forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy93.75 % (15)
Hold6.25 % (1)
Sell0.00 % (0)
12M Price Target
32.64
Last Price
28.18
Currency
USD
12M Return Potential
15.83 %
LTM Return
0 %

BioLife Solutions Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
5/7/20260.02USD26.18 MUSD2026 Q1
5/6/20260.02USD26.18 MUSD2026 Q1
3/2/2026-0.02USD24.56 MUSD2025 Q4
2/26/2026-0.02USD24.56 MUSD2025 Q4
8/7/2025-0.04USD24.18 MUSD2025 Q2
11/12/2024-0.09USD26.05 MUSD2024 Q3
11/7/2024-0.09USD26.05 MUSD2024 Q3
5/8/2024-0.34USD30.78 MUSD2024 Q1
3/14/2024-0.35USD34.50 MUSD2023 Q4
11/7/2023-0.13USD50.98 MUSD2023 Q3

EESG©

Eulerpool ESG Scorecard© for the BioLife Solutions stock

24/100
25
Environment
35
Social
11
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

BioLife Solutions shareholder structure

% Name
12.47475%
Casdin Capital, LLC
Casdin Capital, LLC
11.30207%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
10.84903%
T. Rowe Price Investment Management, Inc.
T. Rowe Price Investment Management, Inc.
8.00959%
Invesco Advisers, Inc.
Invesco Advisers, Inc.
6.44789%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.15282%
State Street Investment Management (US)
State Street Investment Management (US)
...

BioLife Solutions Executives and Management Board

RG

Mr. Roderick de Greef

(64)

Chairman of the Board, Chief Executive Officer · since 2000

Compensation7.05 M USD
TW

Mr. Troy Wichterman

(40)

Chief Financial Officer

Compensation2.55 M USD
AM

Dr. Aby Mathew

(53)

Chief Scientific Officer, Executive Vice President

Compensation1.73 M USD
KF

Ms. Karen Foster

(65)

Chief Quality and Operations Officer

Compensation1.34 M USD
TB

Mr. Todd Berard

(56)

Chief Commercial Officer

Compensation1.13 M USD

BioLife Solutions Supply Chain

BioLife Solutions Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
5 companies
#Name1M3M6M1Y2YTrend
1
Catalent
0.31
0.66
0.82
0.82
0.77
2
Avantor
0.74
0.85
0.97
0.79
0.57
3
Twinbird
Supplier
0.26
0.72
0.86
0.81
0.43
4
Merck
0.41
0.58
0.88
0.37
0.39
5
Thermo Fisher Scientific
0.86
0.48
0.82
0.12
0.31

Frequently asked questions about BioLife Solutions

BioLife Solutions Inc is a biotech company specializing in developing, manufacturing, and marketing cell and tissue preservation solutions. Their business model revolves around providing innovative products that enhance the effectiveness of biological materials storage and transportation. BioLife Solutions offers a comprehensive portfolio of biopreservation media, enabling improved cell therapies, vaccines, and drug discovery research. By supplying high-quality, proprietary products, BioLife Solutions caters to the needs of various sectors, including regenerative medicine, biobanking, and pharmaceuticals. Through their advanced technologies and solutions, BioLife Solutions Inc aims to support the success of customers in preserving and delivering vital biological materials.

All fundamentals and in-depth analysis of BioLife Solutions

Our stock analysis for BioLife Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioLife Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

BioLife Solutions Stock
BioLife Solutions Revenue→
BioLife Solutions Stock
BioLife Solutions Net Income→
BioLife Solutions Stock
BioLife Solutions P/E→
BioLife Solutions Stock
BioLife Solutions P/S→
BioLife Solutions Stock
BioLife Solutions EBIT→
BioLife Solutions Stock
BioLife Solutions Dividend→
BioLife Solutions Stock
BioLife Solutions Directors Dealings→
BioLife Solutions Stock
BioLife Solutions Stocks→
BioLife Solutions Stock
BioLife Solutions Market capitalization→
BioLife Solutions Stock
BioLife Solutions Debt→
BioLife Solutions Stock
BioLife Solutions Liabilities→
BioLife Solutions Stock
BioLife Solutions Equity→
BioLife Solutions Stock
BioLife Solutions AAQS→
BioLife Solutions Stock
BioLife Solutions Employees→
BioLife Solutions Stock
BioLife Solutions ROE→
BioLife Solutions Stock
BioLife Solutions ROA→
BioLife Solutions Stock
BioLife Solutions ROCE→
BioLife Solutions Stock
BioLife Solutions News→
BioLife Solutions Stock
BioLife Solutions Analyst Price Targets→

Health Stocks

Biolight Life SciencesBiolife SciencesBioLineRxBioLASCO Taiwan CoBioMarin PharmaceuticalBioInvent InternationalBioMaximaBioInfra CoBiomea FusionBiohit OyjBiomericaBiohavenAll Stocks A–Z →